Novacyt S.A. (EPA:ALNOV)
France · Delayed Price · Currency is EUR 0.4430
-0.0050 (-1.12%)
Last updated: Nov 10, 2025, 5:13 PM CET
Novacyt Market Cap
Novacyt has a market cap or net worth of €31.59 million as of November 10, 2025. Its market cap has decreased by -36.48% in one year.
Market Cap
31.59M
Enterprise Value
16.70M
Revenue
22.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.44
Market Cap Chart
Since October 12, 2012, Novacyt's market cap has increased from 23.55M to 31.59M, an increase of 34.13%. That is a compound annual growth rate of 2.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 31.59M | -25.61% |
| Dec 31, 2024 | 42.47M | -15.60% |
| Dec 29, 2023 | 50.32M | -42.02% |
| Dec 30, 2022 | 86.78M | -71.94% |
| Dec 31, 2021 | 309.30M | -55.31% |
| Dec 31, 2020 | 692.08M | 6,955.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 142.22B |
| Sanofi | 103.96B |
| Sartorius Stedim Biotech | 18.34B |
| bioMérieux | 12.59B |
| Eurofins Scientific SE | 10.34B |
| Ipsen | 10.18B |
| ABIVAX Société Anonyme | 6.68B |
| Virbac | 2.89B |